Ceftaroline Exhibits Promising In Vitro Activity Against Methicillin-Resistant Staphylococcus aureus Clinical Isolates From Alexandria, Egypt
Conclusions: From various clinical samples, ceftaroline demonstrated excellent in vitro activity against MRSA strains, positioning it as a promising therapeutic option for managing MRSA infections in Egypt.
Saved in:
| Main Authors: | Hussien H. Sallam, Asmaa A. Ramadan, Nancy M. Attia, Amira ElBaradei, Sherine M. Shawky, Mohammed A. El-Kholy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | International Journal of Microbiology |
| Online Access: | http://dx.doi.org/10.1155/ijm/4558662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Mechanisms of Ceftaroline Susceptibility Reduction in Methicillin-Resistant Staphylococcus aureus
by: V. V. Gostev, et al.
Published: (2020-05-01) -
Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremia
by: Addison S. Hicks, et al.
Published: (2025-01-01) -
Genetic Epidemiology and Resistance Investigations of Clinical Yeasts in Alexandria, Egypt
by: Bram Spruijtenburg, et al.
Published: (2025-05-01) -
Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus
by: Kaylee E. Caniff, et al.
Published: (2024-11-01) -
Acute medication poisoning in children at Alexandria Poison Centre, Egypt: an educational intervention
by: Mostafa Arafa, et al.
Published: (2025-06-01)